Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer, January 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 203 articles:
HTML format


 

Single Articles

  1. PANKAJ S, Kumari A, Choudhary V, Jee B, et al
    Cervical cancer in Bihar: Time to revisit the shortcomings.
    Indian J Cancer. 2018;55:203-204.
    Abstract    



  2. NAYAK A, Das S, Nayak D, Sethy C, et al
    Nanoquinacrine sensitizes 5-FU-resistant cervical cancer stem-like cells by down-regulating Nectin-4 via ADAM-17 mediated NOTCH deregulation.
    Cell Oncol (Dordr). 2019 Jan 3. pii: 10.1007/s13402-018-0417.
    Abstract    

    Abstract available

  3. KHALIFE D, El Housheimi A, Khalil A, Saba C S, et al
    Treatment of cervical cancer metastatic to the abdominal wall with reconstruction using a composite myocutaneous flap: A case report.
    Gynecol Oncol Rep. 2018;27:38-41.
    Abstract    

    Abstract available

  4. KASA AS, Tesfaye TD, Temesgen WA
    Knowledge, attitude and practice towards cervical cancer among women in Finote Selam city administration, West Gojjam Zone, Amhara Region, North West Ethiopia, 2017.
    Afr Health Sci. 2018;18:623-636.
    Abstract    

    Abstract available

  5. FOGLEMAN C, Leaman L
    Prophylactic Vaccination Against Human Papillomavirus to Prevent Cervical Cancer and Its Precursors.
    Am Fam Physician. 2019;99:15-16.
    Abstract    



  6. HAMMER A, Soegaard V, Maimburg RD, Blaakaer J, et al
    Cervical cancer screening history prior to a diagnosis of cervical cancer in Danish women aged 60 years and older-A national cohort study.
    Cancer Med. 2019 Jan 1. doi: 10.1002/cam4.1926.
    Abstract    

    Abstract available

  7. WANG L, Li J, Shi X, Li S, et al
    Antimalarial Dihydroartemisinin triggers autophagy within HeLa cells of human cervical cancer through Bcl-2 phosphorylation at Ser70.
    Phytomedicine. 2019;52:147-156.
    Abstract    

    Abstract available

  8. JELIC M, Mandic A, Kladar N, Sudji J, et al
    Lipid Peroxidation, Antioxidative Defense and Level of 8-hydroxy-2-deoxyguanosine in Cervical Cancer Patients.
    J Med Biochem. 2018;37:336-345.
    Abstract    

    Abstract available

  9. EDLER M, Fernandez A, Anderson K, Pierce JY, et al
    HPV vaccination, knowledge, and attitudes among young cervical cancer survivors in the Deep South.
    Vaccine. 2018 Dec 28. pii: S0264-410X(18)31712.
    Abstract    

    Abstract available

  10. PARMIN NA, Hashim U, Gopinath SCB, Nadzirah S, et al
    Human Papillomavirus E6 biosensing: Current progression on early detection strategies for cervical Cancer.
    Int J Biol Macromol. 2018 Dec 28. pii: S0141-8130(18)34909.
    Abstract    

    Abstract available

  11. HALLOWELL BD, Saraiya M, Thompson TD, Unger ER, et al
    Population-Based Assessment of HPV Genotype-Specific Cervical Cancer Survival: CDC Cancer Registry Sentinel Surveillance System.
    JNCI Cancer Spectr. 2018;2.
    Abstract    

    Abstract available

  12. AWOLUDE OA, Oyerinde SO
    INVASIVE CERVICAL CANCER IN IBADAN: SOCIO-SEXUAL CHARACTERISTICS, CLINICAL STAGE AT PRESENTATION, HISTOPATHOLOGY DISTRIBUTIONS AND HIV STATUS.
    Afr J Infect Dis. 2018;13:32-38.
    Abstract    

    Abstract available

  13. DAG Z, Yilmaz B, Dogan AK, Aksan DU, et al
    Comparison of the prognostic value of F-18 FDG PET/CT metabolic parameters of primary tumors and MRI findings in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Brachytherapy. 2018 Dec 26. pii: S1538-4721(18)30066.
    Abstract    

    Abstract available

  14. MENG FF, Feng YH
    A pilot study of acupuncture at pain acupoints for cervical cancer pain.
    Medicine (Baltimore). 2018;97:e13736.
    Abstract    

    Abstract available

  15. LIU Y, Guo JZ, Liu Y, Wang K, et al
    Nuclear lactate dehydrogenase A senses ROS to produce alpha-hydroxybutyrate for HPV-induced cervical tumor growth.
    Nat Commun. 2018;9:4429.
    Abstract    

    Abstract available

  16. ISLAM JY, Hoyt AM, Ramos S, Morgan K, et al
    Acceptability of two- versus three-dose human papillomavirus vaccination schedule among providers and mothers of adolescent girls: a mixed-methods study in five countries.
    Cancer Causes Control. 2018;29:1115-1130.
    Abstract    

    Abstract available

  17. NAVARRO-VIDAL E, Hernandez-Rosas F, Rey M, Flores-Peredo L, et al
    Prevalence of Human Papillomavirus Genotypes in Women from Cozumel, Mexico
    Asian Pac J Cancer Prev. 2018;19:2417-2422.
    Abstract    

    Abstract available

  18. PEDER LD, Silva CM, Boeira VL, Plewka J, et al
    Association between Human Papillomavirus and Non-cervical Genital Cancers in Brazil: A Systematic Review and Meta-Analysis
    Asian Pac J Cancer Prev. 2018;19:2359-2371.
    Abstract    

    Abstract available

  19. WANG Y, Liu Y, Li Z, Yan X, et al
    Association Between MALAT1 and THRIL Polymorphisms and Precancerous Cervical Lesions.
    Genet Test Mol Biomarkers. 2018;22:509-517.
    Abstract    

    Abstract available

  20. KAWATA S, Saito E
    An exploratory pilot study on health education program to improve health literacy among female in their 20s.
    BMC Res Notes. 2018;11:572.
    Abstract    

    Abstract available

  21. SHAHBAZI S, Bolhassani A
    Comparison of six cell penetrating peptides with different properties for in vitro and in vivo delivery of HPV16 E7 antigen in therapeutic vaccines.
    Int Immunopharmacol. 2018;62:170-180.
    Abstract    

    Abstract available

  22. LI P, Liu P, Chen C, Duan H, et al
    The 3D reconstructions of female pelvic autonomic nerves and their related organs based on MRI: a first step towards neuronavigation during nerve-sparing radical hysterectomy.
    Eur Radiol. 2018;28:4561-4569.
    Abstract    

    Abstract available

  23. ALVAREZ-ROMERO JT, Cabrera Vertti MR, Gutierrez Lore S, Tamayo JAG, et al
    PROFICIENCY TEST OF THE SSDL-ININ-MEXICO FOR THE CALIBRATION OF WELL-TYPE CHAMBERS WITH HDR 192IR SOURCES USING TWO DIFFERENT DOSIMETRY CODES OF PRACTICE FOR THE DETERMINATION OF REFERENCE AIR KERMA RATE KR.
    Radiat Prot Dosimetry. 2018;182:221-234.
    Abstract    

    Abstract available

  24. TUSUPKALIEV A, Sarsembaeva L, Abdrakhmanova A, Ayazbaeva L, et al
    [THE CONDITION OF THE CERVIX IN WOMEN LIVING IN OIL AND GAS BEARING AREAS].
    Georgian Med News. 2018;.
    Abstract    

    Abstract available

  25. MRKLAS KJ, MacDonald S, Shea-Budgell MA, Bedingfield N, et al
    Barriers, supports, and effective interventions for uptake of human papillomavirus- and other vaccines within global and Canadian Indigenous peoples: a systematic review protocol.
    Syst Rev. 2018;7:40.
    Abstract    

    Abstract available

  26. NAI GA, Bazan A, Rocha CA, Nagy JS, et al
    Postpartum Genital Melanoma - A Case Report.
    Rev Bras Ginecol Obstet. 2018;40:163-167.
    Abstract    

    Abstract available

  27. MASSEY PM, Budenz A, Leader A, Fisher K, et al
    What Drives Health Professionals to Tweet About #HPVvaccine? Identifying Strategies for Effective Communication.
    Prev Chronic Dis. 2018;15:E26.
    Abstract    

    Abstract available

  28. DALLAZEM B, Dambros BP, Gamba CO, Perazzoli M, et al
    Comparison of Cervicovaginal Cytopathological Samples Collected in Basic Health Units and in Private Clinics in the Midwest of Santa Catarina.
    Rev Bras Ginecol Obstet. 2018;40:86-91.
    Abstract    

    Abstract available

  29. LEUNG JTC, Law CK
    Revisiting knowledge, attitudes and practice (KAP) on human papillomavirus (HPV) vaccination among female university students in Hong Kong.
    Hum Vaccin Immunother. 2018;14:924-930.
    Abstract    

    Abstract available

  30. LOPEZ N, Gil-de-Miguel A, Pascual-Garcia R, Gil-Prieto R, et al
    Reduction in the burden of hospital admissions due to cervical disease from 2003-2014 in Spain.
    Hum Vaccin Immunother. 2018;14:917-923.
    Abstract    

    Abstract available

  31. SAUER AG, Liu B, Siegel RL, Jemal A, et al
    Comparing cancer screening estimates: Behavioral Risk Factor Surveillance System and National Health Interview Survey.
    Prev Med. 2018;106:94-100.
    Abstract    

    Abstract available

  32. FRANK LA, Gazzi RP, Mello P, Buffon A, et al
    Imiquimod-loaded nanocapsules improve cytotoxicity in cervical cancer cell line.
    Eur J Pharm Biopharm. 2019 Jan 7. pii: S0939-6411(18)31231.
    Abstract    

    Abstract available

  33. VAN DYNE EA, Hallowell BD, Saraiya M, Senkomago V, et al
    Establishing Baseline Cervical Cancer Screening Coverage - India, 2015-2016.
    MMWR Morb Mortal Wkly Rep. 2019;68:14-19.
    Abstract    

    Abstract available

  34. KISLING K, Zhang L, Simonds H, Fakie N, et al
    Fully Automatic Treatment Planning for External-Beam Radiation Therapy of Locally Advanced Cervical Cancer: A Tool for Low-Resource Clinics.
    J Glob Oncol. 2019;:1-9.
    Abstract    

    Abstract available

  35. CHEN X, Xiong D, Ye L, Yang H, et al
    SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines.
    Cancer Chemother Pharmacol. 2019 Jan 9. pii: 10.1007/s00280-018-3759.
    Abstract    

    Abstract available

  36. HAN MS, Lee JM, Kim SN, Kim JH, et al
    Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer.
    Biomed Res Int. 2018;2018:1942867.
    Abstract    

    Abstract available

  37. PFAFF C, Singano V, Akello H, Amberbir A, et al
    Early experiences in integrating cervical cancer screening and treatment into HIV services in Zomba Central Hospital, Malawi.
    Malawi Med J. 2018;30:211-214.
    Abstract    

    Abstract available

  38. QIN S, Gao Y, Yang Y, Zhang L, et al
    Identifying Molecular Markers of Cervical Cancer Based on Competing Endogenous RNA Network Analysis.
    Gynecol Obstet Invest. 2019 Jan 9:1-10. doi: 10.1159/000493476.
    Abstract    

    Abstract available

  39. CHEN Y, Xiong X, Wang Y, Zhao J, et al
    Proteomic Screening for Serum Biomarkers for Cervical Cancer and Their Clinical Significance.
    Med Sci Monit. 2019;25:288-297.
    Abstract    

    Abstract available

  40. LEE HY, Beltran R, Kim NK, Lee DK, et al
    Racial Disparities in Cervical Cancer Screening: Implications for Relieving Cervical Cancer Burden in Asian American Pacific Islander Women.
    Cancer Nurs. 2019 Jan 8. doi: 10.1097/NCC.0000000000000642.
    Abstract    

    Abstract available

  41. SAKAKIBARA A, Matsui K, Katayama T, Higuchi T, et al
    Age-related survival disparity in stage IB and IIB cervical cancer patients.
    J Obstet Gynaecol Res. 2019 Jan 8. doi: 10.1111/jog.13891.
    Abstract    

    Abstract available

  42. SINGLA AA, Komesaroff P
    Self-collected Pap smears may provide an acceptable and effective method of cervical cancer screening.
    Health Sci Rep. 2018;1:e33.
    Abstract    

    Abstract available

  43. ALDOHAIAN AI, Alshammari SA, Arafah DM
    Using the health belief model to assess beliefs and behaviors regarding cervical cancer screening among Saudi women: a cross-sectional observational study.
    BMC Womens Health. 2019;19:6.
    Abstract    

    Abstract available

  44. CI LQ, Huang ZG, Lv FM, Wang J, et al
    Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer.
    Pharmaceutics. 2019;11.
    Abstract    

    Abstract available

  45. MUNOZ JP, Carrillo-Beltran D, Aedo-Aguilera V, Calaf GM, et al
    Tobacco Exposure Enhances Human Papillomavirus 16 Oncogene Expression via EGFR/PI3K/Akt/c-Jun Signaling Pathway in Cervical Cancer Cells.
    Front Microbiol. 2018;9:3022.
    Abstract    

    Abstract available

  46. GULSEREN V, Kocaer M, Gungorduk O, Ozdemir IA, et al
    Stage IB1 cervical cancer treated with modified radical or radical hysterectomy: does size determine risk factors?
    Ginekol Pol. 2018;89:667-671.
    Abstract    

    Abstract available

  47. POPADIUK C, Decker K, Gauvreau C
    Starting cervical cancer screening at 25 years of age: the time has come.
    CMAJ. 2019;191:E1-E2.
    Abstract    



  48. MOODLEY J, Constant D, Botha MH, van der Merwe FH, et al
    Exploring the feasibility of using mobile phones to improve the management of clients with cervical cancer precursor lesions.
    BMC Womens Health. 2019;19:2.
    Abstract    

    Abstract available

  49. BIANCHI FP, Gallone MS, Fortunato F, Boccalini S, et al
    Epidemiology and cost of cervical cancer care and prevention in Apulia (Italy), 2007/2016.
    Ann Ig. 2018;30:490-501.
    Abstract    

    Abstract available

  50. MACLAUGHLIN KL, Jacobson RM, Radecki Breitkopf C, Wilson PM, et al
    Trends Over Time in Pap and Pap-HPV Cotesting for Cervical Cancer Screening.
    J Womens Health (Larchmt). 2019 Jan 7. doi: 10.1089/jwh.2018.7380.
    Abstract    

    Abstract available

  51. YUAN LY, Qin X, Li L, Zhou J, et al
    Overexpression of LINC00037 represses cervical cancer progression by activating mTOR signaling pathway.
    J Cell Physiol. 2019 Jan 5. doi: 10.1002/jcp.28012.
    Abstract    

    Abstract available

  52. LI X, Li S, Wang X, Zhao S, et al
    [Knocking down fascin inhibits cervical cancer cell proliferation and tumorigenesis in nude mice].
    Nan Fang Yi Ke Da Xue Xue Bao. 2018;38:1409-1414.
    Abstract    

    Abstract available

  53. YOSHIDA K, Kajiyama H, Yoshihara M, Ikeda Y, et al
    Does postoperative prophylactic irradiation of para-aortic lymph nodes reduce the risk of recurrence in uterine cervical cancer with positive pelvic lymph nodes?
    Int J Clin Oncol. 2019 Jan 5. pii: 10.1007/s10147-018-1376.
    Abstract    

    Abstract available

  54. JI N, Wang Y, Bao G, Yan J, et al
    LncRNA SNHG14 promotes the progression of cervical cancer by regulating miR-206/YWHAZ.
    Pathol Res Pract. 2018 Dec 26. pii: S0344-0338(18)31432.
    Abstract    

    Abstract available

  55. ZHANG Y, Li G, Ji C
    Inhibition of human cervical cancer cell growth by Salviolone is mediated via autophagy induction, cell migration and cell invasion suppression, G2/M cell cycle arrest and downregulation of Nf-kB/m-TOR/PI3K/AKT pathway.
    J BUON. 2018;23:1739-1744.
    Abstract    

    Abstract available

  56. WEN X, Wen D, Yang Y, Chen Y, et al
    Urban-rural disparity in cervical cancer in China and feasible interventions for tackling the rural excess.
    Medicine (Baltimore). 2019;98:e13907.
    Abstract    

    Abstract available

  57. ZONG S, Liu X, Zhou N, Yue Y, et al
    E2F7, EREG, miR-451a and miR-106b-5p are associated with the cervical cancer development.
    Arch Gynecol Obstet. 2019 Jan 4. pii: 10.1007/s00404-018-5007.
    Abstract    

    Abstract available

  58. ZHAO X, Song X, Zhao J, Zhu W, et al
    Juglone inhibits proliferation of HPV-positive cervical cancer cells specifically.
    Biol Pharm Bull. 2018 Dec 28. doi: 10.1248/bpb.b18-00845.
    Abstract    

    Abstract available

  59. SAIDU R, Moodley J, Tergas A, Momberg M, et al
    South African women's perspectives on self-sampling for cervical cancer screening: A mixed-methods study.
    S Afr Med J. 2018;109:47-52.
    Abstract    

    Abstract available

  60. GUO GZ, Zhao Y
    [Analysis of cervical cancer screening results in women aged 50 and older in Beijing and Guizhou].
    Zhonghua Zhong Liu Za Zhi. 2018;40:922-926.
    Abstract    

    Abstract available

  61. ZHAO FH, Zhang L
    [Prophylactic human papilloma virus vaccines launch the era of comprehensive cervical cancer control].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2019;53:10-12.
    Abstract    

    Abstract available

  62. BHATT S, Isaac R, Finkel M, Evans J, et al
    Mobile technology and cancer screening: Lessons from rural India.
    J Glob Health. 2018;8:020421.
    Abstract    

    Abstract available

  63. HU Y, Sun B, Zhao B, Mei D, et al
    Cisplatin-induced cardiotoxicity with midrange ejection fraction: A case report and review of the literature.
    Medicine (Baltimore). 2018;97:e13807.
    Abstract    

    Abstract available

  64. ERNSTSON A, Asciutto KC, Sturesson J, Noren J, et al
    Detection of HPV mRNA in Self-collected Vaginal Samples Among Women at 69-70 Years of Age.
    Anticancer Res. 2019;39:381-386.
    Abstract    

    Abstract available

  65. YE F, Wang H, Liu J, Cheng Q, et al
    Genetic polymorphism (rs246079) of the DNA repair gene uracil N-glycosylase is associated with increased risk of cervical carcinoma in a Chinese population.
    Medicine (Baltimore). 2018;97:e13694.
    Abstract    

    Abstract available

  66. BYUN JM, Jeong DH, Kim YN, Jung EJ, et al
    Persistent HPV-16 infection leads to recurrence of high-grade cervical intraepithelial neoplasia.
    Medicine (Baltimore). 2018;97:e13606.
    Abstract    

    Abstract available

  67. REYNEL M, Villegas Y, Kiene H, Werthmann PG, et al
    Intralesional and subcutaneous application of Viscum album L. (European mistletoe) extract in cervical carcinoma in situ: A CARE compliant case report.
    Medicine (Baltimore). 2018;97:e13420.
    Abstract    

    Abstract available

  68. YU JH, Shi WW, Zhou MY, Liu JM, et al
    Genetic variability and oncogenic risk association of human papillomavirus type 58 E6 and E7 genes in Taizhou area, China.
    Gene. 2019;686:171-176.
    Abstract    

    Abstract available

  69. GU WY, Tao X, Zhang LL, Wang L, et al
    [Synchronous mucinous metaplasia and neoplasia of the female genital tract].
    Zhonghua Bing Li Xue Za Zhi. 2018;47:845-850.
    Abstract    

    Abstract available

  70. SHARMA VR, Thomas SD, Miller DM, Rezzoug F, et al
    Nucleolin Overexpression Confers Increased Sensitivity to the Anti-Nucleolin Aptamer, AS1411.
    Cancer Invest. 2018;36.
    Abstract    

    Abstract available

  71. ISHIKAWA M, Nakamura K, Shibata T, Tanaka K, et al
    A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab vs dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent or persistent cervical carcinoma: Japan Clinical Oncol
    Jpn J Clin Oncol. 2018;48:1096-1100.
    Abstract    

    Abstract available

  72. CARHART MY, Schminkey DL, Mitchell EM, Keim-Malpass J, et al
    Barriers and Facilitators to Improving Virginia's HPV Vaccination Rate: A Stakeholder Analysis With Implications for Pediatric Nurses.
    J Pediatr Nurs. 2018;42:1-8.
    Abstract    

    Abstract available

  73. REGMI S, Fung TS, Lim S, Luo KQ, et al
    Fluidic shear stress increases the anti-cancer effects of ROS-generating drugs in circulating tumor cells.
    Breast Cancer Res Treat. 2018;172:297-312.
    Abstract    

    Abstract available

  74. PONCE-BENAVENTE L, Rejas-Pinelo P, Aguilar-Luis MA, Palomares-Reyes C, et al
    Frequency and coinfection between genotypes of human papillomavirus in a population of asymptomatic women in northern Peru.
    BMC Res Notes. 2018;11:530.
    Abstract    

    Abstract available

  75. DEGAREGE A, Krupp K, Fennie K, Srinivas V, et al
    Human Papillomavirus Vaccine Acceptability among Parents of Adolescent Girls in a Rural Area, Mysore, India.
    J Pediatr Adolesc Gynecol. 2018;31:583-591.
    Abstract    

    Abstract available

  76. TOPAZIAN HM, Kundu D, Peebles K, Ramos S, et al
    HPV Vaccination Recommendation Practices among Adolescent Health Care Providers in 5 Countries.
    J Pediatr Adolesc Gynecol. 2018;31:575-582.
    Abstract    

    Abstract available

  77. QIU J, Zhang H, Wang Z
    Auricularia auriculajudae polysaccharide-cisplatin complexes conjugated with folic acid as new tumor targeting agents.
    Int J Biol Macromol. 2018;120.
    Abstract    

    Abstract available

  78. FREEMAN SC, Fisher D, Tierney JF, Carpenter JR, et al
    A framework for identifying treatment-covariate interactions in individual participant data network meta-analysis.
    Res Synth Methods. 2018;9:393-407.
    Abstract    

    Abstract available

  79. ALEKSANDROV R, Dotchev A, Poser I, Krastev D, et al
    Protein Dynamics in Complex DNA Lesions.
    Mol Cell. 2018;69:1046-1061.
    Abstract    

    Abstract available

  80. WILANDER E

    Lakartidningen. 2018;115.
    Abstract    



  81. HAZAWA M, Lin DC, Kobayashi A, Jiang YY, et al
    ROCK-dependent phosphorylation of NUP62 regulates p63 nuclear transport and squamous cell carcinoma proliferation.
    EMBO Rep. 2018;19:73-88.
    Abstract    

    Abstract available

  82. ANDERSON A, Taylor Z, Georges R, Carlson-Cosentino M, et al
    Primary Care Physicians' Role in Parental Decision to Vaccinate with HPV Vaccine: Learnings from a South Texas Hispanic Patient Population.
    J Immigr Minor Health. 2018;20:1236-1242.
    Abstract    

    Abstract available

  83. KAWASHIMA A, Isohashi F, Mabuchi S, Sawada K, et al
    A 3-year follow-up study of radiotherapy using computed tomography-based image-guided brachytherapy for cervical cancer.
    J Radiat Res. 2019 Jan 11. pii: 5288300. doi: 10.1093.
    Abstract    

    Abstract available

  84. YUAN YG, Zhang S, Hwang JY, Kong IK, et al
    Silver Nanoparticles Potentiates Cytotoxicity and Apoptotic Potential of Camptothecin in Human Cervical Cancer Cells.
    Oxid Med Cell Longev. 2018;2018:6121328.
    Abstract    

    Abstract available

  85. KOUYOUMDJIAN FG, McConnon A, Herrington ERS, Fung K, et al
    Cervical Cancer Screening Access for Women Who Experience Imprisonment in Ontario, Canada.
    JAMA Netw Open. 2018;1:e185637.
    Abstract    

    Abstract available

  86. ELIT LM, Fyles AW, Gu CS, Pond GR, et al
    Effect of Positron Emission Tomography Imaging in Women With Locally Advanced Cervical Cancer: A Randomized Clinical Trial.
    JAMA Netw Open. 2018;1:e182081.
    Abstract    

    Abstract available

  87. HELMAN SR, Stevanovic S, Campbell TE, Kwong MLM, et al
    Human Papillomavirus T-Cell Cross-reactivity in Cervical Cancer: Implications for Immunotherapy Clinical Trial Design.
    JAMA Netw Open. 2018;1:e180706.
    Abstract    

    Abstract available

  88. ARAYA LT, Gebretekle GB, Gebremariam GT, Fenta TG, et al
    Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
    Health Qual Life Outcomes. 2019;17:13.
    Abstract    

    Abstract available

  89. GUO Q, Xiong Y, Song Y, Hua K, et al
    ARHGAP17 suppresses tumor progression and up-regulates P21 and P27 expression via inhibiting PI3K/AKT signaling pathway in cervical cancer.
    Gene. 2019 Jan 11. pii: S0378-1119(19)30024-1. doi: 10.1016/j.gene.2019.
    Abstract    

    Abstract available

  90. CHARLTON BM, Kahn JA, Sarda V, Katz-Wise SL, et al
    Maternal Factors and Sexual Orientation-Related Disparities in Cervical Cancer Prevention.
    Womens Health Issues. 2019 Jan 10. pii: S1049-3867(18)30414.
    Abstract    

    Abstract available

  91. COHEN PA, Jhingran A, Oaknin A, Denny L, et al
    Cervical cancer.
    Lancet. 2019;393:169-182.
    Abstract    

    Abstract available

  92. THE LANCET
    Cervical cancer: unequal progress.
    Lancet. 2019;393:104.
    Abstract    



  93. HUANG WC, Hsiao YC, Wu CC, Hsu YT, et al
    Less circulating mucosal-associated invariant T cells in patients with cervical cancer.
    Taiwan J Obstet Gynecol. 2019;58:117-121.
    Abstract    

    Abstract available

  94. ALI A, Kim MJ, Kim MY, Lee HJ, et al
    Quercetin induces cell death in cervical cancer by reducing O-GlcNAcylation of adenosine monophosphate-activated protein kinase.
    Anat Cell Biol. 2018;51:274-283.
    Abstract    

    Abstract available

  95. SMITH-GAGEN J, White LL, Santos A, Hasty SM, et al
    Scope-of-practice laws and expanded health services: the case of underserved women and advanced cervical cancer diagnoses.
    J Epidemiol Community Health. 2019 Jan 11. pii: jech-2018-210709.
    Abstract    

    Abstract available

  96. WORONOFF AS, Molinie F, Tretarre B
    [Implementation of National Cervical Cancer Screening Program in France].
    Bull Cancer. 2019 Jan 8. pii: S0007-4551(18)30370.
    Abstract    

    Abstract available

  97. GANGOPADHYAY A
    Neutrophil lymphocyte ratio is significantly associated with complete response to chemoradiation in locally advanced cervical cancer.
    Acta Oncol. 2019 Jan 11:1-3. doi: 10.1080/0284186X.2018.1556803.
    Abstract    



  98. SONG T, Xu A, Zhang Z, Gao F, et al
    CircRNA hsa_circRNA_101996 increases cervical cancer proliferation and invasion through activating TPX2 expression by restraining miR-8075.
    J Cell Physiol. 2019 Jan 11. doi: 10.1002/jcp.28128.
    Abstract    

    Abstract available

  99. HAN X, Wang Q, Wang Y, Hu B, et al
    Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1/microRNA-202-3p/periostin axis modulates invasion and epithelial-mesenchymal transition in human cervical cancer.
    J Cell Physiol. 2019 Jan 11. doi: 10.1002/jcp.28113.
    Abstract    

    Abstract available

  100. REN W, Mohammed SI, Wereley ST, Irudayaraj J, et al
    Magnetic focus lateral flow sensor for detection of cervical cancer biomarkers.
    Anal Chem. 2019 Jan 11. doi: 10.1021/acs.analchem.8b04848.
    Abstract    

    Abstract available

  101. NYAMBE N, Hoover S, Pinder LF, Chibwesha CJ, et al
    Differences in Cervical Cancer Screening Knowledge and Practices by HIV Status and Geographic Location: Implication for Program Implementation in Zambia.
    Afr J Reprod Health. 2018;22:92-101.
    Abstract    

    Abstract available

  102. GUO JL, Han T, Bao L, Li XM, et al
    Ursolic acid promotes the apoptosis of cervical cancer cells by regulating endoplasmic reticulum stress.
    J Obstet Gynaecol Res. 2019 Jan 10. doi: 10.1111/jog.13919.
    Abstract    

    Abstract available

  103. JIA QP, Yan CY, Zheng XR, Pan X, et al
    Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-kappaB/APOBEC3B cascade.
    Cancer Chemother Pharmacol. 2019 Jan 10. pii: 10.1007/s00280-018-03766.
    Abstract    

    Abstract available

  104. NUCHPRAMOOL P, Hanprasertpong J
    Preoperative Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Not Clinically Useful in Predicting Prognosis in Early Stage Cervical Cancer.
    Surg Res Pract. 2018;2018:9162921.
    Abstract    

    Abstract available

  105. CHO O, Chun M
    Management for locally advanced cervical cancer: new trends and controversial issues.
    Radiat Oncol J. 2018;36:254-264.
    Abstract    

    Abstract available

  106. WILEY R, Shelal Z, Urbauer D, Bernard C, et al
    Relationship Between Intent to Vaccinate and the Education and Knowledge of Human Papillomavirus Among Medical School Faculty and Students in Texas.
    Tex Med. 2019;115:e1.
    Abstract    

    Abstract available

  107. LI Z, Song S, He M, Wang D, et al
    Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity.
    Nat Commun. 2018;9:5360.
    Abstract    

    Abstract available

  108. HU K, Wang W, Liu X, Meng Q, et al
    Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy.
    Radiat Oncol. 2018;13:249.
    Abstract    

    Abstract available

  109. DE LIMA TM, DE Azevedo Focchi GR, DE Almeida BC, Belfort-Mattos PN, et al
    Expression of CK7 and CDKN2 in Cervical Intraepithelial Neoplasia and Correlation with Clinical Outcome.
    Anticancer Res. 2018;38:6673-6681.
    Abstract    

    Abstract available

  110. TORRES-POVEDA K, Bahena-Roman M, Delgado-Romero K, Madrid-Marina V, et al
    A prospective cohort study to evaluate immunosuppressive cytokines as predictors of viral persistence and progression to pre-malignant lesion in the cervix in women infected with HR-HPV: study protocol.
    BMC Infect Dis. 2018;18:582.
    Abstract    

    Abstract available

  111. YIN S, Ma SN, Zhang YQ, Shi TY, et al
    Surgical and oncological outcomes of an improved nerve-sparing radical hysterectomy technique: 6 years of experience at two centres.
    Surg Oncol. 2018;27:380-386.
    Abstract    

    Abstract available

  112. XU L, Padalko E, Ostrbenk A, Poljak M, et al
    Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework.
    Int J Mol Sci. 2018;19.
    Abstract    

    Abstract available

  113. MONJARAS-AVILA C, Bernal-Silva S, Bach H
    Development of Novel Single-Chain Antibodies against the Hydrophobic HPV-16 E5 Protein.
    Biomed Res Int. 2018;2018:5809028.
    Abstract    

    Abstract available

  114. YOSHIBA T, Saga Y, Urabe M, Uchibori R, et al
    CRISPR/Cas9-mediated cervical cancer treatment targeting human papillomavirus E6.
    Oncol Lett. 2019;17:2197-2206.
    Abstract    

    Abstract available

  115. DING M, Zhang H, Liu L, Liang R, et al
    Effect of NOS1 regulating ABCG2 expression on proliferation and apoptosis of cervical cancer cells.
    Oncol Lett. 2019;17:1531-1536.
    Abstract    

    Abstract available

  116. WU L, Wu Y, Xiong Z, Yao C, et al
    Effects and possible mechanism of a picosecond pulsed electric field on angiogenesis in cervical cancer in vitro.
    Oncol Lett. 2019;17:1517-1522.
    Abstract    

    Abstract available

  117. PRATI B, da Silva Abjaude W, Termini L, Morale M, et al
    Three Prime Repair Exonuclease 1 (TREX1) expression correlates with cervical cancer cells growth in vitro and disease progression in vivo.
    Sci Rep. 2019;9:351.
    Abstract    

    Abstract available

  118. KASAMATSU T, Ishikawa M, Murakami N, Okada S, et al
    Identifying selection criteria for non-radical hysterectomy in FIGO stage IB cervical cancer.
    J Obstet Gynaecol Res. 2019 Jan 22. doi: 10.1111/jog.13902.
    Abstract    

    Abstract available

  119. JEONG MH, Kim H, Kim TH, Kim MH, et al
    Prognostic significance of pretreatment lymphocyte percentage and age at diagnosis in patients with locally advanced cervical cancer treated with definite radiotherapy.
    Obstet Gynecol Sci. 2019;62:35-45.
    Abstract    

    Abstract available

  120. ZHENG WL, Zhang H, Wang DZ, Zhang S, et al
    [Analysis on long-term trends of cervical cancer mortality and years of life lost in Tianjin, 1999-2015].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2019;40:64-69.
    Abstract    

    Abstract available

  121. BOCKEL S, Escande A, Dumas I, Manea E, et al
    Total Reference Air Kerma is Associated with Late Bowel Morbidity in Locally Advanced Cervical Cancer Patients Treated with Image-Guided Adaptive Brachytherapy.
    J Clin Med. 2019;8.
    Abstract    

    Abstract available

  122. LIU X, Wang W, Meng Q, Zhang F, et al
    Extended-field intensity-modulated radiation therapy combined with concurrent chemotherapy for cervical cancer with para-aortic lymph nodes metastasis.
    Jpn J Clin Oncol. 2018 Dec 20. pii: 5298914. doi: 10.1093.
    Abstract    

    Abstract available

  123. CUI L, Nai M, Zhang K, Li L, et al
    lncRNA WT1-AS inhibits the aggressiveness of cervical cancer cell via regulating p53 expression via sponging miR-330-5p.
    Cancer Manag Res. 2019;11:651-667.
    Abstract    

    Abstract available

  124. CHEN YP, Liu YW, Lee D, Qiu JT, et al
    Biodegradable andrographolide-eluting nanofibrous membranes for the treatment of cervical cancer.
    Int J Nanomedicine. 2019;14:421-429.
    Abstract    

    Abstract available

  125. BESWICK A, Corkum M, D'Souza D
    Locally advanced cervical cancer in a transgender man.
    CMAJ. 2019;191:E76-E78.
    Abstract    



  126. HOLSCHNEIDER CH, Petereit DG, Chu C, Hsu IC, et al
    Brachytherapy: A critical component of primary radiation therapy for cervical cancer: For the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS).
    Brachytherapy. 2019 Jan 17. pii: S1538-4721(18)30739.
    Abstract    

    Abstract available

  127. LIU J, Peng Y, Li L, Chen Z, et al
    Better resource utilization and quality of care for cervical cancer screening in low-resourced districts using an internet-based expert system.
    Technol Health Care. 2019 Jan 8. pii: THC181577. doi: 10.3233/THC-181577.
    Abstract    

    Abstract available

  128. SONG D, Kong W, Zhang T, Han C, et al
    A retrospective analysis of cisplatin/carboplatin plus paclitaxel in advanced or recurrent cervical cancer.
    J Obstet Gynaecol. 2019 Jan 20:1-6. doi: 10.1080/01443615.2017.1416595.
    Abstract    

    Abstract available

  129. JIANG L, Wang Y, Zhu F, Liu G, et al
    Molecular Mechanism of Anti-Cancer Activity of the Nano-Drug C-PC/CMC-CD59sp NPs in Cervical Cancer.
    J Cancer. 2019;10:92-104.
    Abstract    

    Abstract available

  130. VAN HEERDEN LE, Visser J, Koedooder K, Rasch CR, et al
    Role of deformable image registration for delivered dose accumulation of adaptive external beam radiation therapy and brachytherapy in cervical cancer.
    J Contemp Brachytherapy. 2018;10:542-550.
    Abstract    

    Abstract available

  131. NARTEY Y, Hill P, Amo-Antwi K, Asmah R, et al
    Recommendations for cervical cancer prevention and control in Ghana: public education and human papillomavirus vaccination.
    Ghana Med J. 2018;52:94-102.
    Abstract    

    Abstract available

  132. VIZZA D, Lupinacci S, Toteda G, Puoci F, et al
    An Olive Leaf Extract Rich in Polyphenols Promotes Apoptosis in Cervical Cancer Cells by Upregulating p21(Cip/WAF1) Gene Expression.
    Nutr Cancer. 2019 Jan 19:1-14. doi: 10.1080/01635581.2018.1559934.
    Abstract    

    Abstract available

  133. NILSEN A, Jonsson M, Aarnes EK, Kristensen GB, et al
    Reference MicroRNAs for RT-qPCR Assays in Cervical Cancer Patients and Their Application to Studies of HPV16 and Hypoxia Biomarkers.
    Transl Oncol. 2019;12:576-584.
    Abstract    

    Abstract available

  134. VANSKA S, Bogaards JA, Auranen K, Lehtinen M, et al
    Fast approximate computation of cervical cancer screening outcomes by a deterministic multiple-type HPV progression model.
    Math Biosci. 2019;309:92-106.
    Abstract    

    Abstract available

  135. WANG J, Gao T, Luo Y, Wang Z, et al
    In Vitro Selection of a DNA Aptamer by Cell-SELEX as a Molecular Probe for Cervical Cancer Recognition and Imaging.
    J Mol Evol. 2019 Jan 19. pii: 10.1007/s00239-019-9886.
    Abstract    

    Abstract available

  136. DYER BA, Zamarin D, Eskandar RN, Mayadev JM, et al
    Role of Immunotherapy in the Management of Locally Advanced and Recurrent/Metastatic Cervical Cancer.
    J Natl Compr Canc Netw. 2019;17:91-97.
    Abstract    

    Abstract available

  137. PENNINGTON KP, Urban RR, Gray HJ
    Revisiting Minimally Invasive Surgery in the Management of Early-Stage Cervical Cancer.
    J Natl Compr Canc Netw. 2019;17:86-90.
    Abstract    

    Abstract available

  138. KOH WJ, Abu-Rustum NR, Bean S, Bradley K, et al
    Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
    J Natl Compr Canc Netw. 2019;17:64-84.
    Abstract    

    Abstract available

  139. MARTIN-HIRSCH P, Wood N, Whitham NL, Macdonald R, et al
    Survival of women with early stage cervical cancer in the UK treated with minimal access and open surgery.
    BJOG. 2019 Jan 18. doi: 10.1111/1471-0528.15617.
    Abstract    

    Abstract available

  140. LIU YJ, Zhou HG, Chen LH, Qu DC, et al
    MiR-32-5p regulates the proliferation and metastasis of cervical cancer cells by targeting HOXB8.
    Eur Rev Med Pharmacol Sci. 2019;23:87-95.
    Abstract    

    Abstract available

  141. TANAKA T, Terai Y, Ohmichi M
    Association of matrix metalloproteinase-9 and decorin expression with the infiltration of cervical cancer.
    Oncol Lett. 2019;17:1306-1312.
    Abstract    

    Abstract available

  142. TANG M, Liu Q, Yang X, Chen L, et al
    Perineural invasion as a prognostic risk factor in patients with early cervical cancer.
    Oncol Lett. 2019;17:1101-1107.
    Abstract    

    Abstract available

  143. YONEDA M, Imamura R, Nitta H, Taniguchi K, et al
    Enhancement of cancer invasion and growth via the C5a-C5a receptor system: Implications for cancer promotion by autoimmune diseases and association with cervical cancer invasion.
    Oncol Lett. 2019;17:913-920.
    Abstract    

    Abstract available

  144. RAY A, Jena S, Dash B, Sahoo A, et al
    Hedychium coronarium extract arrests cell cycle progression, induces apoptosis, and impairs migration and invasion in HeLa cervical cancer cells.
    Cancer Manag Res. 2019;11:483-500.
    Abstract    

    Abstract available

  145. ALLENDE G, Surriabre P, Caceres L, Bellot D, et al
    Evaluation of the self-sampling for cervical cancer screening in Bolivia.
    BMC Public Health. 2019;19:80.
    Abstract    

    Abstract available

  146. TRAYNOR D, Duraipandian S, Bhatia R, Cuschieri K, et al
    The potential of biobanked liquid based cytology samples for cervical cancer screening using Raman spectroscopy.
    J Biophotonics. 2019 Jan 17:e201800377. doi: 10.1002/jbio.201800377.
    Abstract    

    Abstract available

  147. ZHANG J, Li Z, Ma X, Feng H, et al
    A pathological toe fracture as the first presentation of cervical cancer: A case report.
    Medicine (Baltimore). 2019;98:e14190.
    Abstract    

    Abstract available

  148. XU X, Liu T, Wu J, Wang Y, et al
    Transferrin receptor-involved HIF-1 signaling pathway in cervical cancer.
    Cancer Gene Ther. 2019 Jan 17. pii: 10.1038/s41417-019-0078.
    Abstract    

    Abstract available

  149. SELMOUNI F, Belakhel L, Sauvaget C, Abousselham L, et al
    Evaluation of the national cervical cancer screening program in Morocco: achievements and challenges.
    J Med Screen. 2019 Jan 16:969141318824627. doi: 10.1177/0969141318824627.
    Abstract    

    Abstract available

  150. GARZA-MORALES R, Perez-Trujillo JJ, Martinez-Jaramillo E, Saucedo-Cardenas O, et al
    A DNA Vaccine Encoding SA-4-1BBL Fused to HPV-16 E7 Antigen Has Prophylactic and Therapeutic Efficacy in a Cervical Cancer Mouse Model.
    Cancers (Basel). 2019;11.
    Abstract    

    Abstract available

  151. ESBER A, Norris A, Jumbe E, Kandodo J, et al
    Feasibility, validity and acceptability of self-collected samples for human papillomavirus (HPV) testing in rural Malawi.
    Malawi Med J. 2018;30:61-66.
    Abstract    

    Abstract available

  152. LI RZ, Hou J, Wei Y, Luo X, et al
    hnRNPDL extensively regulates transcription and alternative splicing.
    Gene. 2019;687:125-134.
    Abstract    

    Abstract available

  153. PEPRAH S, Coleman JS, Rositch AF, Vanden Bussche CJ, et al
    Utilization of Pap testing among women living with HIV enrolled in primary care in Baltimore, Maryland: A 10-year longitudinal study, 2005-2014.
    Papillomavirus Res. 2018;6:52-57.
    Abstract    

    Abstract available

  154. TOLIMAN PJ, Kaldor JM, Badman SG, Gabuzzi J, et al
    Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial les
    Papillomavirus Res. 2018;6:70-76.
    Abstract    

    Abstract available

  155. WANG X, Lin W, Zhang W, Li C, et al
    Amphiphilic redox-sensitive NIR BODIPY nanoparticles for dual-mode imaging and photothermal therapy.
    J Colloid Interface Sci. 2019;536:208-214.
    Abstract    

    Abstract available

  156. FENG X, Zhang D, Li X, Ma S, et al
    CXCL5, the upregulated chemokine in patients with uterine cervix cancer, in vivo and in vitro contributes to oncogenic potential of Hela uterine cervix cancer cells.
    Biomed Pharmacother. 2018;107:1496-1504.
    Abstract    

    Abstract available

  157. CHEN B, Wang J, Wang J, Zhang J, et al
    The Study of MDM2 rs937283 Variant and Cancer Susceptibility in a Central Chinese Population.
    Technol Cancer Res Treat. 2018;17:1533033818801550.
    Abstract    

    Abstract available

  158. FOSTER L, Robson SJ
    Association between a national quality improvement program and excisional treatment of cervical dysplasia in Australia.
    J Obstet Gynaecol Res. 2018;44:2085-2090.
    Abstract    

    Abstract available

  159. ZHANG R, Ge X, You K, Guo Y, et al
    p16/Ki67 dual staining improves the detection specificity of high-grade cervical lesions.
    J Obstet Gynaecol Res. 2018;44:2077-2084.
    Abstract    

    Abstract available

  160. ISLA-ORTIZ D, Salcedo-Hernandez RA, Leon-Takahashi AM, Estrada-Rivera F, et al
    [Resultados quirurgicos de histerectomia radical laparoscopica en pacientes con cancer de cervix en etapa temprana: experiencia inicial en Instituto de Cancer].
    Cir Cir. 2018;86:220-227.
    Abstract    

    Abstract available

  161. OKONOGI N, Fukahori M, Wakatsuki M, Ohkubo Y, et al
    Dose constraints in the rectum and bladder following carbon-ion radiotherapy for uterus carcinoma: a retrospective pooled analysis.
    Radiat Oncol. 2018;13:119.
    Abstract    

    Abstract available

  162. BRETAGNE CH, Jooste V, Guenat D, Riethmuller D, et al
    Prevalence and distribution of HPV genotypes and cervical-associated lesions in sexually active young French women following HPV vaccine.
    J Gynecol Obstet Hum Reprod. 2018;47:525-531.
    Abstract    

    Abstract available

  163. MA X, Wang Q, Ong JJ, Fairley CK, et al
    Prevalence of human papillomavirus by geographical regions, sexual orientation and HIV status in China: a systematic review and meta-analysis.
    Sex Transm Infect. 2018;94:434-442.
    Abstract    

    Abstract available

  164. FISCHER G, Cormier K
    Glandular Cell Abnormalities on SurePath Preparations: A Retrospective Review with Cytology-Histology Correlations.
    Acta Cytol. 2018;62.
    Abstract    

    Abstract available

  165. MCHUGH KE, Reynolds JP, Suarez AA
    Postmenopausal Squamous Atypia: Cytologic Features, Hybrid Capture 2 Tests and Contribution to the ASCUS Pool.
    Acta Cytol. 2018;62.
    Abstract    

    Abstract available

  166. EDBLAD-SVENSSON A, Silfverdal L, Collberg P, Tunon K, et al
    High-Risk Types of Human Papilloma Virus DNA Testing in Women with False Negative Cytology.
    Acta Cytol. 2018;62.
    Abstract    

    Abstract available

  167. KOMATSU H, Oishi T, Osaku D, Sawada M, et al
    Significance of High-Risk Human Papillomavirus Testing for Atypical Glandular Cells on Cervical Cytology.
    Acta Cytol. 2018;62.
    Abstract    

    Abstract available

  168. LEPE M, Eklund CM, Quddus MR, Paquette C, et al
    Atypical Glandular Cells: Interobserver Variability according to Clinical Management.
    Acta Cytol. 2018;62.
    Abstract    

    Abstract available

  169. LEITE KRM, Silva T, Naum B, Canavez F, et al
    Validation of a New Low-Cost, Methanol-Based Fixative for Cervical Cytology and Human Papillomavirus Detection.
    Acta Cytol. 2018;62.
    Abstract    

    Abstract available

  170. OLIVEIRA GG, Oliveira JMDSC, Eleuterio RMN, Barbosa RCC, et al
    Atypical Squamous Cells: Cytopathological Findings and Correlation with HPV Genotype and Histopathology.
    Acta Cytol. 2018;62.
    Abstract    

    Abstract available

  171. LAM JUH, Elfstrom KM, Ejegod DM, Pedersen H, et al
    High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders.
    Br J Cancer. 2018;118:138-144.
    Abstract    

    Abstract available

  172. YAGI A, Ueda Y, Kakuda M, Tanaka Y, et al
    Epidemiological and clinical analyses of cervical cancer using data from the population-based Osaka cancer registry.
    Cancer Res. 2019 Jan 11. pii: 0008-5472.CAN-18-3109.
    Abstract    

    Abstract available

  173. KIM SI, Cho JH, Seol A, Kim YI, et al
    Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1-IIA2 cervical cancer.
    Gynecol Oncol. 2019 Jan 11. pii: S0090-8258(19)30041.
    Abstract    

    Abstract available

  174. HOLSCHNEIDER CH, Petereit DG, Chu C, Hsu IC, et al
    Brachytherapy: A critical component of primary radiation therapy for cervical cancer: For the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS).
    Gynecol Oncol. 2019 Jan 17. pii: S0090-8258(18)31297.
    Abstract    

    Abstract available

  175. GAFFNEY DK, Hashibe M, Kepka D, Maurer KA, et al
    Too many women are dying from cervix cancer: Problems and solutions.
    Gynecol Oncol. 2018;151:547-554.
    Abstract    

    Abstract available

  176. GOMIH A, Smith JS, North KE, Hudgens MG, et al
    DNA methylation of imprinted gene control regions in the regression of low-grade cervical lesions.
    Int J Cancer. 2018;143:552-560.
    Abstract    

    Abstract available

  177. DEL MISTRO A, Adcock R, Carozzi F, Gillio-Tos A, et al
    HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2.
    Int J Cancer. 2018 Feb 17. doi: 10.1002/ijc.31326.
    Abstract    

    Abstract available

  178. RIETBERGEN MM, van Bokhoven AAJD, Lissenberg-Witte BI, Heideman DAM, et al
    Epidemiologic associations of HPV-positive oropharyngeal cancer and (pre)cancerous cervical lesions.
    Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31315.
    Abstract    

    Abstract available

  179. LUOSTARINEN T, Apter D, Dillner J, Eriksson T, et al
    Vaccination protects against invasive HPV-associated cancers.
    Int J Cancer. 2017 Dec 26. doi: 10.1002/ijc.31231.
    Abstract    



  180. ANNUNZIATA C, Pezzuto F, Greggi S, Ionna F, et al
    Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma.
    Int J Cancer. 2018 Mar 31. doi: 10.1002/ijc.31412.
    Abstract    

    Abstract available

  181. BAUSSANO I, Lazzarato F, Ronco G, Franceschi S, et al
    Impacts of human papillomavirus vaccination for different populations: A modeling study.
    Int J Cancer. 2018;143:1086-1092.
    Abstract    

    Abstract available

  182. OBERLIN AM, Rahangdale L, Chinula L, Fuseini NM, et al
    Making HPV vaccination available to girls everywhere.
    Int J Gynaecol Obstet. 2018 Aug 24. doi: 10.1002/ijgo.12656.
    Abstract    

    Abstract available

  183. YALCIN I, Sari ME, Sahin H, Gultekin M, et al
    Colposcopic biopsy findings among women with either HPV-16 only or HPV-18 only who have normal cervical cytology.
    Int J Gynaecol Obstet. 2018 Aug 20. doi: 10.1002/ijgo.12652.
    Abstract    

    Abstract available

  184. CHEN M, Cai H, Chen S, Wu X, et al
    Comparative analysis of transcervical resection and loop electrosurgical excision in the treatment of high-grade cervical intraepithelial neoplasia.
    Int J Gynaecol Obstet. 2018;143:306-312.
    Abstract    

    Abstract available

  185. CIBULA D, Dusek J, Jarkovsky J, Dundr P, et al
    A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX).
    Int J Gynecol Cancer. 2019;29:212-215.
    Abstract    

    Abstract available

  186. CORDERO-GALLARDO F, Lee Burnett O 3rd, McNamara MM, Weber TM, et al
    Incidence of mesorectal node metastasis in locally advanced cervical cancer: its therapeutic implications.
    Int J Gynecol Cancer. 2019;29:48-52.
    Abstract    

    Abstract available

  187. YAVAS G, Yavas C, Sen E, Oner I, et al
    Adjuvant carboplatin and paclitaxel after concurrent cisplatin and radiotherapy in patients with locally advanced cervical cancer.
    Int J Gynecol Cancer. 2019;29:42-47.
    Abstract    

    Abstract available

  188. NEWMAN H, Hu J, Li X, He J, et al
    Evaluation of portable colposcopy and human papillomavirus testing for screening of cervical cancer in rural China.
    Int J Gynecol Cancer. 2019;29:23-27.
    Abstract    

    Abstract available

  189. YOSHINO Y, Taguchi A, Shimizuguchi T, Nakajima Y, et al
    A low albumin to globulin ratio with a high serum globulin level is a prognostic marker for poor survival in cervical cancer patients treated with radiation based therapy.
    Int J Gynecol Cancer. 2019;29:17-22.
    Abstract    

    Abstract available

  190. CHONG GO, Han HS, Park JY, Lee SD, et al
    Prevalence, survival outcomes, and clinicopathologic factors associated with negative high risk human papillomavirus in surgical specimens of cervical cancer with pretreatment negative DNA genotype test.
    Int J Gynecol Cancer. 2019;29:10-16.
    Abstract    

    Abstract available

  191. RAJASOORIYAR C, Lin MY, Kalra R, Lim A, et al
    The role of positron emission tomography in the selection of patients for salvage hysterectomy following chemoradiotherapy for locally advanced cervical cancer.
    Int J Gynecol Cancer. 2019 Jan 10. pii: ijgc-2018-000088.
    Abstract    

    Abstract available

  192. HATA M
    Radiation therapy for elderly patients with uterine cervical cancer: feasibility of curative treatment.
    Int J Gynecol Cancer. 2019 Jan 10. pii: ijgc-2018-000077.
    Abstract    

    Abstract available

  193. HOREWEG N, Creutzberg CL, Rijkmans EC, Laman MS, et al
    Efficacy and toxicity of chemoradiation with image-guided adaptive brachytherapy for locally advanced cervical cancer.
    Int J Gynecol Cancer. 2019 Jan 10. pii: ijgc-2018-000057.
    Abstract    

    Abstract available

  194. RAMIREZ PT, Abu-Rustum NR, Euscher E
    Conservative management of cervical cancer in pregnancy.
    Int J Gynecol Cancer. 2019 Jan 23. pii: ijgc-2018-000187.
    Abstract    



  195. HORNE ZD, Karukonda P, Kalash R, Edwards RP, et al
    Single-institution experience in 3D MRI-based brachytherapy for cervical cancer for 239 women: can dose overcome poor response?
    Int J Radiat Oncol Biol Phys. 2018 Dec 31. pii: S0360-3016(18)34224.
    Abstract    

    Abstract available

  196. LIU GC, Zhou YF, Su XC, Zhang J, et al
    Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study.
    BMC Cancer. 2019;19:24.
    Abstract    

    Abstract available

  197. LOU H, Gharzouzi E, Guerra SP, Domgue JF, et al
    Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala.
    BMC Cancer. 2018;18:562.
    Abstract    

    Abstract available

  198. MABEYA H, Menon S, Weyers S, Naanyu V, et al
    Uptake of three doses of HPV vaccine by primary school girls in Eldoret, Kenya; a prospective cohort study in a malaria endemic setting.
    BMC Cancer. 2018;18:557.
    Abstract    

    Abstract available

  199. ITTIAMORNLERT P, Ruengkhachorn I
    Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy.
    BMC Cancer. 2019;19:51.
    Abstract    

    Abstract available

  200. SUZUKI Y, Tokinaga-Uchiyama A, Mizushima T, Maruyama Y, et al
    Normalization of abnormal plasma amino acid profile-based indexes in patients with gynecological malignant tumors after curative treatment.
    BMC Cancer. 2018;18:973.
    Abstract    

    Abstract available

  201. TEMPFER CB, Tischoff I, Dogan A, Hilal Z, et al
    Neuroendocrine carcinoma of the cervix: a systematic review of the literature.
    BMC Cancer. 2018;18:530.
    Abstract    

    Abstract available

  202. BERTAUT A, Coudert J, Bengrine L, Dancourt V, et al
    Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    PLoS One. 2018;13:e0198939.
    Abstract    

    Abstract available

  203. MACHIDA H, Matsuo K, Furusawa A, Kita T, et al
    Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan.
    PLoS One. 2019;14:e0210125.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;